| |
| |
|
| Insider
Information: |
Kolterman Orville G |
| Relationship: |
SVP, Chief Medical Off... |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
0 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Amylin Pharmaceuticals Inc |
AMLN |
SVP, Chief Medical Off... |
2012-08-08 |
0 |
2012-08-08 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
141 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AMLN |
Amylin Pharmaceuticals In... |
Sr VP Clinical and Regulatory |
• – – |
2008-02-01 |
4 |
A |
$37.00 |
$6,734 |
D/D |
182 |
120,169 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Sr VP Clinical and Regulatory |
• – – |
2005-09-16 |
4 |
GD |
$0.00 |
$0 |
D/D |
250 |
110,510 |
|
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Senior Vice President |
• – – |
2003-08-01 |
4 |
OE |
$4.50 |
$1,350 |
D/D |
300 |
61,226 |
|
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Senior Vice President |
• – – |
2003-08-01 |
4 |
AS |
$23.98 |
$7,194 |
D/D |
(300) |
60,926 |
|
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
SVP Research & Development |
• – – |
2010-02-03 |
4 |
A |
$17.83 |
$7,346 |
D/D |
412 |
144,839 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Sr VP Clinical and Regulatory |
• – – |
2007-01-31 |
4 |
A |
$36.07 |
$15,005 |
D/D |
416 |
118,866 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Sr VP Clinical and Regulatory |
• – – |
2006-01-31 |
4 |
A |
$19.46 |
$13,788 |
D/D |
431 |
110,941 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Sr VP Clinical and Regulatory |
• – – |
2009-02-03 |
4 |
A |
$11.80 |
$6,903 |
D/D |
585 |
126,921 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Sr VP Clinical and Regulatory |
• – – |
2007-02-28 |
4 |
A |
$33.07 |
$21,961 |
D/D |
664 |
119,530 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Senior Vice President |
• – – |
2004-04-21 |
4 |
D |
$24.68 |
$32,652 |
D/D |
(1,323) |
68,265 |
|
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
SVP Research & Development |
• – – |
2010-02-03 |
4 |
A |
$0.00 |
$0 |
I/I |
1,360 |
4,815 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
SVP, Chief Medical OfficerSVP, |
• – – |
2012-07-25 |
4 |
A |
$14.62 |
$20,117 |
D/D |
1,376 |
185,653 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
SVP, Chief Medical OfficerSVP, |
• – – |
2012-03-06 |
4 |
A |
$0.00 |
$0 |
I/I |
1,529 |
7,974 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
SVP, Chief Medical Officer |
• – – |
2011-03-01 |
4 |
A |
$0.00 |
$0 |
I/I |
1,630 |
6,445 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Sr VP Clinical and Regulatory |
• – – |
2007-08-01 |
4 |
OE |
$9.63 |
$16,363 |
D/D |
1,700 |
121,230 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Sr VP Clinical and Regulatory |
• – – |
2007-08-01 |
4 |
AS |
$46.50 |
$79,050 |
D/D |
(1,700) |
119,530 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
SVP, Chief Medical OfficerSVP, |
• – – |
2012-03-01 |
4 |
S |
$17.11 |
$31,585 |
D/D |
(1,846) |
174,277 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Sr VP Clinical and Regulatory |
• – – |
2005-08-25 |
4 |
AS |
$30.34 |
$60,680 |
D/D |
(2,000) |
110,760 |
|
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Sr VP Clinical and Regulatory |
• – – |
2005-08-25 |
4 |
OE |
$14.38 |
$28,750 |
D/D |
2,000 |
112,760 |
|
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Sr VP Clinical and Regulatory |
• – – |
2005-09-30 |
4 |
OE |
$2.91 |
$5,812 |
D/D |
2,000 |
112,510 |
|
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Sr VP Clinical and Regulatory |
• – – |
2005-09-30 |
4 |
AS |
$34.90 |
$69,800 |
D/D |
(2,000) |
110,510 |
|
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Sr VP Clinical and Regulatory |
• – – |
2005-11-03 |
4 |
AS |
$34.90 |
$69,800 |
D/D |
(2,000) |
110,510 |
|
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Sr VP Clinical and Regulatory |
• – – |
2005-11-03 |
4 |
OE |
$0.31 |
$626 |
D/D |
2,000 |
112,510 |
|
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Senior Vice President |
• – – |
2004-04-23 |
4 |
S |
$25.03 |
$52,938 |
D/D |
(2,115) |
66,150 |
|
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Sr VP Clinical Affairs |
• – – |
2005-03-01 |
4 |
AS |
$21.31 |
$46,882 |
D/D |
(2,200) |
94,833 |
|
- |
|
141 Records found
|
|
Page 1 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
